Today's Reuters Health News Headlines - Yahoo! News:
|
|
Gingrich fights off rivals in Iowa debate
Sat,10 Dec 2011 08:17 PM PST
Reuters -  DES MOINES, Iowa (Reuters) - Surging frontrunner Newt Gingrich fought off heavy attacks in a presidential debate in Iowa on Saturday from Republican rivals who portrayed him as a Washington insider and questioned his judgment. Gingrich, portrayed by critics at times as rash and petulant, kept his cool as his Republican rivals criticized him for making up to $1.6 million from housing giant Freddie Mac, for saying Palestinians were an "invented" people and for his troubled marital past. ...
Full Story | Top |
Romney's $10,000 bet falls flat in Iowa debate
Sat,10 Dec 2011 07:58 PM PST
Reuters -  DES MOINES (Reuters) - Republican presidential candidate Mitt Romney put his money where his mouth was on Saturday in a quip at a presidential debate that may have backfired. Romney, a multi-millionaire and a frontrunner for the Republican nomination, offered a $10,000 bet to opponent Texas Gov. Rick Perry in an argument over what Romney wrote about healthcare in his book "No Apologies." Former Massachusetts governor Romney tried to bet that he had not supported implementing an individual healthcare mandate, mistrusted by conservatives. "Rick, I'll tell you what: 10,000 bucks?," Romney said. ...
Full Story | Top |
Gene therapy proves effective for hemophilia B
Sat,10 Dec 2011 07:11 PM PST
Reuters - SAN DIEGO (Reuters) - A single treatment with gene therapy, an experimental technique for fixing faulty genes, has been shown to boost output of a vital blood clotting factor, possibly offering a long-term solution for people with hemophilia B. Researchers said the same technology was also being studied as a treatment for hemophilia A, the far more common type of the inherited bleeding disorder. "It is a technique for potentially permanently curing patients," said Dr. ... Full Story | Top |
Gene therapy proves effective for hemophilia B
Sat,10 Dec 2011 12:42 PM PST
Reuters - SAN DIEGO (Reuters) - A single treatment with gene therapy, an experimental technique for fixing faulty genes, has been shown for the first time to boost output of a vital blood clotting factor, possibly offering a long-term solution for people with hemophilia B. Researchers said the same technology was also being studied as a treatment for hemophilia A, the far more common type of the inherited bleeding disorder. "It is a technique for potentially permanently curing patients," said Dr. ... Full Story | Top |
Gingrich vs Romney rivalry in Iowa debate spotlight
Sat,10 Dec 2011 12:25 PM PST
Reuters -  DES MOINES, Iowa (Reuters) - The budding rivalry between surging Newt Gingrich and former frontrunner Mitt Romney will take center stage on Saturday in the first of two Republican presidential debates in Iowa over the next five days. Gingrich, Romney and four other White House contenders will make their case to voters in a race that polls show is still up for grabs less than a month before Iowa kicks off the state-by-state Republican nominating contest. The debate will be broadcast nationally on ABC at 9 p.m. EST from Drake University in Des Moines. ...
Full Story | Top |
Leukemia drug pulled from U.S. sparks new interest
Sat,10 Dec 2011 11:56 AM PST
Reuters - SAN DIEGO (Reuters) - A new study of leukemia drug Mylotarg, pulled from the U.S. market last year due to safety concerns, found it to be effective when used at low doses in older adults but questions about toxicity remain. Pfizer Inc voluntarily halted U.S. sales of Mylotarg, also known as gemtuzumab, after a study showed that adding it to chemotherapy did not extend survival for patients with previously untreated acute myeloid leukemia (AML), an aggressive bone marrow cancer. That trial also showed more deaths in the first couple of months of treatment. The fatality rate was 5. ... Full Story | Top |
Stem cells used to produce blood platelets
Sat,10 Dec 2011 11:35 AM PST
Reuters - SAN DIEGO (Reuters) - Scientists have for the first time created blood platelet cells by reprogramming stem cells derived from adult cells, offering the potential for a renewable supply of the fragile blood component. Researchers at the Center for iPS Cell Research and Application at Kyoto University in Japan presented data at a meeting of the American Society of Hematology showing they were able to create the cells in the laboratory and confirm they had the same life span as normal human platelets when infused in mice. ... Full Story | Top |
Olympus ousted CEO to visit Japan
Sat,10 Dec 2011 04:15 AM PST
Reuters -  TOKYO (Reuters) - Olympus Corp's ousted CEO, Michael Woodford, flies to Japan on Tuesday to press on with a battle to win back his job, as media reported that prosecutors plan to raid the homes of suspects in a $1.7 billion accounting fraud at the camera maker. Woodford wants to meet potential candidates for a new management team for which he will also seek shareholder and investor backing when the board comes up for election at an extraordinary shareholders' meeting, possibly in February. He will leave Japan on Friday morning, an assistant in Tokyo said in an e-mail. ...
Full Story | Top |
Hospital fire kills at least 84 in eastern India
Sat,10 Dec 2011 03:48 AM PST
Reuters -  KOLKATA, India (Reuters) - A fire tore through a seven-story private hospital in the eastern Indian city of Kolkata before dawn Friday, killing at least 84 people, most of them intensive care patients who were asleep and suffocated in the fumes. Thick smoke engulfed the crowded hospital and fire-fighters smashed windows to evacuate people down ladders and with sheets from upper floors. Other patients were wheeled out on trolleys. Rescue workers and locals criticised a lack of safety equipment and said staff fled the scene leaving windows and doors locked. ...
Full Story | Top |
McIlroy should make full recovery, says tour physician
Fri,9 Dec 2011 11:57 PM PST
Reuters -  DUBAI (Reuters) - Rory McIlroy's viral illness is a common problem among travelling golfers and the world number two should make a complete recovery as long as he takes some rest, the European Tour's chief medical officer has said. The 22-year-old has had a punishing playing schedule in Asia recently and his management team told Reuters at the Dubai World Championship on Friday that he was "exhausted" and "run down". "This isn't an unusual situation in my experience on the tour," medical officer Roger Hawkes told Reuters on Saturday. ...
Full Story | Top |
Golf-McIlroy should make full recovery, says tour physician
Fri,9 Dec 2011 11:48 PM PST
Reuters - DUBAI, Dec 10 (Reuters) - Rory McIlroy's viral illnessis a common problem among travelling golfers and the worldnumber two should make a complete recovery as long as he takessome rest, the European Tour's chief medical officer has said. The 22-year-old has had a punishing playing schedule in Asiarecently and his management team told Reuters at the Dubai WorldChampionship on Friday that he was "exhausted" and "run down". "This isn't an unusual situation in my experience on thetour," medical officer Roger Hawkes told Reuters on Saturday. ... Full Story | Top |
Romney hits Gingrich on Medicare reform
Fri,9 Dec 2011 06:04 PM PST
Reuters -  CEDAR RAPIDS, Iowa (Reuters) - Republican Mitt Romney hit surging presidential rival Newt Gingrich on Friday over Medicare reform but left the toughest criticisms to surrogates who hinted at Gingrich's troubled marital past. One day before a debate in Iowa, which holds the first contest in the Republican nominating race in less than a month, Romney also contrasted his business experience and leadership with Gingrich's "30 or 40 years in Washington." "There's nothing wrong with that," Romney told the Des Moines Register's editorial board. "It's just different. ...
Full Story | Top |
FDA advisers: Ortho Evra patch needs clearer label
Fri,9 Dec 2011 03:13 PM PST
Reuters - ADELPHI, Maryland (Reuters) - U.S. drug advisers recommended that the label for Johnson and Johnson's Ortho Evra birth control patch be simplified to better explain the risk of blood clots. In a 20 to 3 vote with one abstention, advisers to the Food and Drug Administration found that the current label for Ortho Evra inadequately reflects the risks women face by using it. It is the only contraceptive patch sold in the United States. The panel voted 19 to 5 that the patch's risks were outweighed by its benefits, such as pregnancy prevention through a once-weekly application. ... Full Story | Top |
Republican Romney hits Gingrich over Medicare plan
Fri,9 Dec 2011 02:32 PM PST
Reuters - CEDAR RAPIDS, Iowa (Reuters) - Republican Mitt Romney hit surging presidential rival Newt Gingrich in Iowa on Friday for attacking a Republican plan to reform Medicare but left the harshest criticism to his campaign surrogates. On a visit to Iowa, which holds the first contest in the Republican nominating race in less than a month, Romney reminded voters Gingrich had attacked U.S. House of Representatives Budget Committee Chairman Paul Ryan's Medicare plan last spring as "right-wing social engineering. ...
Full Story | Top |
FDA advisers stand behind Ortho Evra patch
Fri,9 Dec 2011 02:23 PM PST
Reuters - ADELPHI, Maryland (Reuters) - Drug advisers recommended that the label for Johnson and Johnson's Ortho Evra birth control patch should be simplified to better explain the risk of blood clots. Advisers to the Food and Drug Administration, in a sweeping 20 to three vote with one abstention on Friday, found the current label for Ortho Evra, the only contraceptive patch sold in the country, inadequately reflects the risks women face by using it. ... Full Story | Top |
| |
|
No comments:
Post a Comment